The USFDA has approved the first-ever blood test to help diagnose Alzheimer's disease, offering a faster, less invasive, and ...

The first blood test to help diagnose Alzheimer's disease will be available from late June in the US following regulatory ...

The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

The first blood test to help diagnose Alzheimer’s disease will be available from late June in the US following regulatory ...

Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal brain function.

Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...